Press/Media
- 225 - 250 out of 303 results
Search results
-
A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities
2/10/18
1 item of Media coverage
Press/Media
-
Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
2/10/18
1 item of Media coverage
Press/Media
-
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
2/10/18
1 item of Media coverage
Press/Media
-
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer
2/10/18
1 item of Media coverage
Press/Media
-
Abiraterone Acetate Trial in African American Prostate Cancer Patients
2/10/18
1 item of Media coverage
Press/Media
-
Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion.
29/09/18
1 item of Media coverage
Press/Media
-
WCE 2018: Multiparametric MRI Features Identify Aggressive Prostate Cancer At the Phenotypic ...
Isuru Jayaratna, & Ashutosh Tewari
21/09/18
1 item of Media coverage
Press/Media
-
Protected: New Treatment Options Reduce Fear Of Advanced Prostate Cancer
Deepak Kapoor,
7/09/18
1 item of Media coverage
Press/Media
-
Discovery could lead to higher immunotherapy response rates for bladder cancer patients
29/08/18 → 30/08/18
2 items of Media coverage
Press/Media
-
Researchers discover reason why many bladder cancer patients do not respond to immunotherapy
29/08/18
1 item of Media coverage
Press/Media
-
Discovery Could Lead to Higher Response Rates for Bladder Cancer Patients Treated with Immunotherapy
29/08/18
2 items of Media coverage
Press/Media
-
Caris Life Sciences Selected to Perform Genomic Profiling for Hoosier Cancer Research Network Bladder Cancer Study
28/08/18
12 items of Media coverage
Press/Media
-
-
Healio - Strict cancer trial eligibility criteria ensure patient safety, but ‘pendulum has swung too far’
10/08/18
1 item of Media coverage
Press/Media
-
UTIs Found to Be a Lot More Common Than Originally Thought
9/08/18
1 item of Media coverage
Press/Media
-
ZERO BRINGS PROSTATE CANCER RUN/WALK SERIES TO NEW YORK CITY
Jay Motola,
2/08/18
1 item of Media coverage
Press/Media
-
Clinical Trial: A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
29/06/18
1 item of Media coverage
Press/Media
-
Expert Talks Immunotherapy, Unanswered Questions in Metastatic Bladder Cancer
22/06/18
1 item of Media coverage
Press/Media
-
Metastatic Urothelial Cancer: 'PD-1/PD-L1 Inhibitors Poised to Impact Standard of Care'
15/06/18
1 item of Media coverage
Press/Media
-
Ask Mount Sinai: Everything you need to know about prostate screening
Michael Palese,
4/06/18 → 5/06/18
2 items of Media coverage
Press/Media
-
-
Concurrent Chemo, Immunotherapy Offers Viable Option in Metastatic Bladder Cancer
21/04/18
2 items of Media coverage
Press/Media
-
Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer
12/04/18 → 13/04/18
2 items of Media coverage
Press/Media
-
Simultaneous Chemotherapy and Immunotherapy May Be Better for Some Metastatic Bladder Cancer Patients
11/04/18 → 13/04/18
51 items of Media coverage
Press/Media
-
Simultaneous Chemotherapy and Immunotherapy May Be Better for Some Metastatic Bladder Cancer Patients [T-break Tech (Middle East)]
12/04/18
1 item of Media coverage
Press/Media